The University of Chicago Header Logo

Connection

En-Ling Wu to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications En-Ling Wu has written about Antibodies, Monoclonal, Humanized.
En-Ling Wu
Connection Strength
0.033
Antibodies, Monoclonal, Humanized
  1. Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study. Clin Infect Dis. 2022 01 07; 74(1):24-31.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.